Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Mar 5, 2024
Date Accepted: Sep 10, 2024
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Electronic Health Interventions for Cervical Cancer screening: a Systematic Review and Meta-Analysis
ABSTRACT
Background:
Cervical cancer is an important cause of death in women. Although screening has decreased the mortality of cervical cancer, the screening rates remain suboptimal.
Objective:
This systematic review and meta-analysis aims to determine the effectiveness of electronic health intervention for cervical cancer screening.
Methods:
We searched for randomized controlled trials of electronic health interventions promoting cervical cancer screening in adults in MEDLINE, Cochrane Central Registry of Controlled Trials, Embase, PsycINFO, PubMed, Scopus, Web of Science, and Cumulative Index to Nursing and Allied Health Literature on Dec. 29, 2023. In addition to doing risk of bias evaluations, two impartial reviewers went over the titles, abstracts, and full-text publications. The Mantel-Haenszel method was utilized in a random-effects model to pool the relative risk for involvement in cervical cancer screening.
Results:
A screen of 713 records identified 14 studies with 23102 participants that were included in the final analysis. The results indicated that electronic health was more effective than control conditions for improving cervical cancer screening rates (RR, 1.464; 95% CI, 1.285–1.667; P < 0.001; I2 = 84.3%); cervical cancer screening (RR, 1.382; 95% CI, 1.214–1.574; P < 0.001; I2 = 82.0%); cervical cancer screening(RR, 1.565; 95% CI, 1.381–1.772; P < 0.001; I2 = 73.6%).
Conclusions:
Given their potential to increase participation in cancer screening, screening programs ought to take electronic health interventions into account. Clinical Trial: CRD42024502884
Citation
